| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |